Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Medicine, Breast cancer, Oncology, Internal medicine, Cancer, and Metastatic breast cancer.
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk
Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer
Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer
Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer
Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies
CAPTOR-BC: Comprehensive analysis of spatial, temporal and molecular biomarkers predicting response and resistance to first-line treatment with ribociclib + ET in HR+, HER2- advanced breast cancer.
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry
Update Breast Cancer 2022 Part 2 – Advanced Stage Breast Cancer
Update Breast Cancer 2022 Part 4 – Advanced-Stage Breast Cancer
Update Breast Cancer 2021 Part 4 – Prevention and Early Stages
Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
Update Breast Cancer 2022 Part 1 – Early Stage Breast Cancer
Return of individual genomic research results within the PRAEGNANT multicenter registry study
Update Mammakarzinom 2021 Teil 5 – fortgeschrittenes Mammakarzinom
Update Breast Cancer 2022 Part 3 – Early-Stage Breast Cancer
Update Mammakarzinom 2021 Teil 2 – fortgeschrittene Stadien, Langzeitfolgen und Biomarker
Correction: Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer